The 6th JMAC Symposium Program
| The 6th JMAC Symposium Program Day 1 | ||
| Thursday, January 24, 2019 | ||
| Day1 | Registration：9:30～10:00 | Tokyo International Forum B5 |
| Session１: International standards and innovation in biotech field Chair：Dr. Hiroki Nakae（JMAC） |
||
|
10:00～10:05 |
Welcome Remarks Ministry of Economy, Trade and Industry (METI) |
|
|
10:05～10:10 |
Introduction of Session 1 “International standards and innovation in biotech field” Dr. Hiroki Nakae／JMAC |
|
|
10:10～10:40 |
Conformity assessment in biobanking spectrum Dr. Koh Furuta／Kanagawa Cancer Center |
|
|
10:40～11:10 |
A Summary of Current Standardization Activities in ISO/TC276 Biotechnology Clare M. Allocca／National Institute of Standards & Technology (NIST, USA) |
|
|
11:10～11:30 |
International standardization for cell-based assay using bioluminescence measurement Dr. Naohiro Noda／AIST |
|
|
11:30～11:50 |
Safety Assessment in the Coming Era of the Precision Medicine Dr. Yuko Sekino／Tokyo University |
|
|
11:50～13:10 |
Break and Posters | |
|
13:10～13:40 |
Two-Tailed PCR for precision diagnostics Dr. Mikael Kubista／TATAA Biocenter（Sweden） |
|
| 13:40～14:10 | FIRM (The Forum for Innovative Regenerative Medicine) pursuing international standardization Mr. Tatsuo Heki／Forum for Innovative Regenerative Medicine（FIRM）・FUJIFILM Corporation Dr. Yutaka Yanagita／Forum for Innovative Regenerative Medicine（FIRM）・Astellas Pharma Inc. |
|
| Session２: AMED miRNA Project Reports Part I Dr. Takahiro Ochiya（National Cancer Center） |
|
|
14:10～14:15 |
Welcome Remarks Mr. Naoyuki Yamada／AMED |
|
14:15～14:25 |
Introduction of Session 2 “AMED miRNA Project Reports Part I” Dr. Takahiro Ochiya／National Cancer Center |
|
14:25～14:55 |
Recent progress of serum miRNA profiling for the early stage cancer detection Dr. Juntaro Matsuzaki／National Cancer Center |
|
14:55～15:25 |
The role of liquid biopsy in taking precision medicine to new heights Dr. Hiroki Ochiai／National Cancer Center・Kitasato University Kitasato Institute Hospital |
|
15:25～15:55 |
Break and Posters |
|
15:55～16:25 |
Development of a combination marker search algorithm for multiple diseases Mr. Hitoshi Fujimiya／Dynacom Co., Ltd. |
|
16:25～16:55 |
The possibilities and issues of Medical AI Dr. Nobuyuki Ota／Preferred Networks America, Inc. |
|
16:55～17:25 |
Detection of microRNA biomarker for dementia Dr. Shunpei Niida／National Center for Geriatrics and Gerontology |
|
17:25～17:30 |
Wrap up Remarks of Session 2 Dr. Takahiro Ochiya／National Cancer Center |
| 18:00～19:30 | Reception Lounge, Tokyo International Forum ※Registration required |
| The 6th JMAC Symposium Program Day 2 | ||
| Friday, January 25, 2019 | ||
| Day2 | Registration：9:30～10:00 | Tokyo International Forum B5 |
| Session3: AMED miRNA Project Reports Part II Chair：Dr. Hiroki Nakae（JMAC） |
||
|
10:00～10:10 |
Welcome Remarks Dr. Saito Shiro／President of JMAC, Toshiba Corporation |
|
|
10:10～10:15 |
Introduction of Session 3 and follow-up of previous day Dr. Hiroki Nakae／JMAC |
|
|
10:15～10:45 |
Development of DNA chip for the diagnosis with circulating miRNA Dr. Satoko Takizawa／Toray Industries, Inc. |
|
|
10:45～11:00 |
Development of electrochemical miRNA detection technology Dr. Kouji Hashimoto／Toshiba Corporation |
|
|
11:00～11:15 |
Development of a non-PCR based miRNA quantification system for bedside testing Dr. Akio Kobori／Kyoto Institute of Technology Dr. Yuichiro Noda／Arkray Inc. |
|
|
11:15～11:30 |
Development of automated nucleic acid extraction system for exosome and miRNA from body fluids for clinical site inspection Dr. Kazumi Sawakami／Precision System Science Co., Ltd. |
|
|
11:30～12:00 |
miRNA Biomarkers and International Standardization Dr. Hiroki Nakae／JMAC |
|
| 12:00～13:20 |
Break and Posters |
|
| Session 4: “Expectations for Liquid Biopsy Technology” Chair：Dr. Takahiro Ochiya（National Cancer Center） |
|
|
13:20～13:25 |
Welcome Remarks Dr. Hiroshi Kato／Yamaguchi University |
|
13:25～13:55 |
Advances in liquid biopsy for early detection of cancer Dr. Takahiro Ochiya／National Cancer Center |
|
13:55～14:25 |
Unveiling of Extracellular miRNA Profiles of Breast Cancer Dr. Tang-Long Shen／National Taiwan University（Taiwan） |
|
14:25～14:55 |
Rigor and Reproducibility for Liquid Biopsy Dr. Matthew Young／National Cancer Institute（USA） |
|
14:55～15:25 |
Break and Posters |
|
15:25～15:55 |
Application of Liquid Biopsy to Clinical Laboratory Testings Dr. Masato Maekawa／Hamamatsu University School of Medicine |
|
15:55～16:25 |
Cancer precision medicine based on liquid biopsy Dr. Kazuto Nishio／Kindai University |
| 16:25～17:15 | Panel discussion “Expectations for Liquid Biopsy Technology” Dr. Ochiya, Dr. Nakae, Dr. Nishio, Dr. Shen, Dr. Young, Dr. Maekawa |